PSA levels in the blood are now used as the basis of algorithms which, by assessing the changes in its concentration with time, or its levels in relation to other prostate products, can produce a much more robust and reliable pointer for cancer diagnosis and prognosis than simple plasma levels of PSA alone. Here, KLK3 is linked to cancer.